C4B and cyclic hematopoiesis: Nonetheless, the predominant factor influencing the t-CH landscape remains chemotherapy treatment, with both germline predispositions and environmental factors likely contributing to the pool of CH mutations that are subsequently subjected to chemotherapy-induced selection.